Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: J Pharm Biomed Anal. 2011 Jan 5;55(3):603–607. doi: 10.1016/j.jpba.2010.12.027

Table 1.

Intrinsic electrophoretic mobilities of the analytes.

Analyte Background Electrolyte
Condition		 Intrinsic Electrophoretic Mobility
(× 10−4 cm2/s/V) a
Salicylate 0.04 M, PBS −2.9 ± 0.2
Salicylate 0.016 M, PBS −2.8 ± 0.3
Lidocaine 0.16 M, PBS 0.9 ± 0.1
Bovine serum albumin 0.16 M, PBS −1.7 ± 0.2
Bovine serum albumin 0.04 M, PBS −1.9 ± 0.2
Polystyrene sulfonate 0.04 M, PBS −4.4 ± 0.6
Bevacizumab 0.16 M, PBS −0.9 ± 0.2
Ranibizumab 0.16 M, PBS −0.28 ± 0.15
a

mean ± SD (n ≥ 4).